| Research |
RFurther
Reading |
|
further reading |
||
|
journal |
title |
availability |
| Submitted |
Endometrial safety with a low-dose intrauterine levonorgestrel-releasing system after three years of estrogen substitution therapy |
|
|
J Obstet Gynecol Research 2003;29:164-173 |
The "frameless" copper intrauterine system (IUS) for long-term, reversible contraception - a review of 15 years of clinical experience |
|
|
Gynécol Obstét Fertil 2001;29:549-564 |
L’implant contraceptif intra-uterin sans armature (GyneFix®) (nouvel inserteur mark 2) |
|
| Submitted | Three-year efficacy and acceptability of the GyneFix® 200 intrauterine system (IUS) | abstract |
| Submitted |
Menstrual blood loss with a miniature, “frameless”, copper-releasing intrauterine system |
abstract |
|
Maturitas 200 |
Performance
and acceptability of intrauterine release of levonorgestrel with a
miniature delivery system for hormonal substitution therapy, contraception
and treatment in peri- and postmenopausal women |
abstract |
| full text article | ||
|
Am J Obstet Gynecol 2003;138:1297-1298 |
Treatment
of non atypical and atypical endometrial hyperplasia with a new “frameless”
levonorgestrel-relesing intrauterine system: a pilot study |
|
|
Proceedings
IXth European Congress of Pediatric and Adolescent Gynecolo |
Miniature
long-term intrauterine drug delivery for more effective contraception in
adolescents |
|
|
Invited lecture held at the 5th Intrenational Congress on Women's Health and Disease Athens (Greece) 26-29 Sept 2002 (in press) |
Miniature
Intrauterine Drug Delivery Systems |
|
|
Reproductive BioMedicine Online 2002;4:69-80 (www.rbmonline.com) |
Development
of a miniature, low-dose, frameless intrauterine levonorgestrel-releasing
intrauterine system for contraception and treatment: a review of initial
clinical experience |
|
|
Eur
J Contracept & Reprod Health Care 1999;4:15-19 |
GyneFix®-LNG:
preliminary clinical experience with a copper and levonorgestrel-releasing
intrauterine system |
|
|
Contraception
2002;66:93-99 |
Contraception
and treatment in the perimenopause with a novel “frameless”
intrauterine levonorgestrel-releasing drug delivery system |
|
|
Eur
J Obstet Gynecol & Reprod Biol 2002;101:74-79 |
The
effect on menstrual blood loss in women with uterine fibroids of a novel
“frameless” intrauterine levonorgestrel-releasing drug delivery
system: a pilot study |
|
|
Eur
J Contracept & Reprod Health Care 2001;6:93-101 |
Treatment
of menorrhagia with a novel “frameless” intrauterine
levonorgestrel-releasing drug delivery system: a pilot study |
|
|
Eur
J Contracept & Reprod Health Care |
Treatment
of primary and secondary dysmenorrhea with a novel “frameless”
intrauterine levonorgestrel-releasing drug delivery system: a pilot study |
|
|
Eur
J Contracept & Reprod Health Care 2000;5:234-240 |
Contraception
with a novel “frameless” intrauterine levonorgestrel-releasing drug
delivery system: A pilot study |
|
|
Maturitas |
Endometrial
suppression with a new “frameless” levonorgestrel releasing
intrauterine system in perimenopausal and postmenopausal women: a pilot
study |
|
GynePlant™
and FibroPlant™-LNG are research products and are not yet available